Drug Promoters Say Genentech Shorted Them On OT

Law360, New York (June 4, 2012, 1:04 PM EDT) -- Genentech Inc. was hit Friday with a proposed class action in Arizona federal court by an employee who says the company shorts its drug promoters on overtime pay by misclassifying them as exempt.

Genentech pharmaceutical representative Belgium Harris says in his putative collective action that the drugmaker systematically misclassifies its promoters as exempt from the overtime provisions of the Fair Labor Standards Act despite the fact that the workers do not themselves sell Genentech products as the company contends.

“Genentech willfully and illegally classifies all of...
To view the full article, register now.




Case Information

Case Title

Harris v. Genentech Incorporated

Case Number




Nature of Suit

Civil Rights: Jobs


Mark E Aspey

Date Filed

May 31, 2012


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.